Type 2 diabetes mellitus is a chronic disease that affects more than 29 million individuals in the United States.
Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence
It is estimated that 29.1 million people or 9.3% of the US population have diabetes, which contributes to considerable medical and financial burden.
The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes
Rosacea is among the most prevalent dermatoses in the United States, with an estimated prevalence of approximately 16 million affected individuals.
The Challenge of Rosacea Treatment
A Useful Tool for Evaluating Disease Severity and Alternative Treatments Efficacy
Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer
Chronic noncancer pain is a common and debilitating condition that affects approximately 30% of adults in the United States. The management of chronic pain is primarily aimed at relieving the pain and improving physical and emotional functions, although these are not achieved in a substantial number of patients.
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Chronic obstructive pulmonary disease (COPD) is characterized by declining lung function attributable to a combination of airway obstruction and inflammation.
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD

The increasing prevalence of noncommunicable chronic diseases is widely recognized as a significant challenge to US and global healthcare.

The Challenge of Managing Specialty Drugs for Psoriasis

The benefits of statin therapy in reducing cardiovascular (CV) events are immense. In numerous studies, lowering low-density lipoprotein cholesterol (LDL-C) levels with statin therapy has been shown to reduce rates of major adverse CV events, such as myocardial infarction (MI) and stroke.

Using Statin Therapy to Reduce Atherosclerotic Cardiovascular Disease Risk

It has been estimated that approximately 24% of adults in the United States have visible varicose veins, and an estimated 6% have evidence of more advanced chronic venous disease (eg, hyperpigmentation or healed or active ulcer).

Important Insights from Real-World Treatment Patterns and Outcomes for Varicose Veins Management
Page 3 of 12
Results 21 - 30 of 120
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME